These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 32606683)

  • 21. Connecting the dots in drug delivery: A tour d'horizon of chitosan-based nanocarriers system.
    Pramanik S; Sali V
    Int J Biol Macromol; 2021 Feb; 169():103-121. PubMed ID: 33338522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Review on Designing Poly (Lactic-co-glycolic Acid) Nanoparticles as Drug Delivery Systems.
    Naskar S; Das SK; Sharma S; Kuotsu K
    Pharm Nanotechnol; 2021; 9(1):36-50. PubMed ID: 33319695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymer blend microspheres for controlled drug release: the techniques for preparation and characterization: a review article.
    Dasan KP; Rekha C
    Curr Drug Deliv; 2012 Nov; 9(6):588-95. PubMed ID: 22780912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved design and characterization of PLGA/PLA-coated Chitosan based micro-implants for controlled release of hydrophilic drugs.
    Manna S; Donnell AM; Kaval N; Al-Rjoub MF; Augsburger JJ; Banerjee RK
    Int J Pharm; 2018 Aug; 547(1-2):122-132. PubMed ID: 29857096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
    Hadinoto K; Sundaresan A; Cheow WS
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate.
    Lai P; Daear W; Löbenberg R; Prenner EJ
    Colloids Surf B Biointerfaces; 2014 Jun; 118():154-63. PubMed ID: 24769392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tailoring the degradation rate and release kinetics from poly(galactitol sebacate) by blending with chitosan, alginate or ethyl cellulose.
    Natarajan J; Madras G; Chatterjee K
    Int J Biol Macromol; 2016 Dec; 93(Pt B):1591-1602. PubMed ID: 26893047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polylactic acid: synthesis and biomedical applications.
    Singhvi MS; Zinjarde SS; Gokhale DV
    J Appl Microbiol; 2019 Dec; 127(6):1612-1626. PubMed ID: 31021482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eco-friendly chitosan-based nanostructures in diabetes mellitus therapy: Promising bioplatforms with versatile therapeutic perspectives.
    Taheriazam A; Entezari M; Firouz ZM; Hajimazdarany S; Hossein Heydargoy M; Amin Moghadassi AH; Moghadaci A; Sadrani A; Motahhary M; Harif Nashtifani A; Zabolian A; Tabari T; Hashemi M; Raesi R; Jiang M; Zhang X; Salimimoghadam S; Ertas YN; Sun D
    Environ Res; 2023 Jul; 228():115912. PubMed ID: 37068723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PLGA nanoparticles are effective to control the colonic release and absorption on ibuprofen.
    Lozoya-Agullo I; Araújo F; González-Álvarez I; Merino-Sanjuán M; González-Álvarez M; Bermejo M; Sarmento B
    Eur J Pharm Sci; 2018 Mar; 115():119-125. PubMed ID: 29248559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered therapeutic proteins for sustained-release drug delivery systems.
    Nguyen TTK; Pham KY; Yook S
    Acta Biomater; 2023 Nov; 171():131-154. PubMed ID: 37717712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone Regeneration from PLGA Micro-Nanoparticles.
    Ortega-Oller I; Padial-Molina M; Galindo-Moreno P; O'Valle F; Jódar-Reyes AB; Peula-García JM
    Biomed Res Int; 2015; 2015():415289. PubMed ID: 26509156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymer based Gels: Recent and Future Applications in Drug Delivery Field.
    Siafaka PI; Gündoğdu EA; Cağlar ES; Özgenç E; Gonzalez-Alvarez M; Gonzalez-Alvarez I; Okur NÜ
    Curr Drug Deliv; 2023; 20(9):1288-1313. PubMed ID: 36082850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent advances in biopolymer-based hydrogels and their potential biomedical applications.
    Patel DK; Jung E; Priya S; Won SY; Han SS
    Carbohydr Polym; 2024 Jan; 323():121408. PubMed ID: 37940291
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug.
    Wang W; Chen S; Zhang L; Wu X; Wang J; Chen JF; Le Y
    Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():514-20. PubMed ID: 25492016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
    Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PLGA nanoparticles in drug delivery: the state of the art.
    Bala I; Hariharan S; Kumar MN
    Crit Rev Ther Drug Carrier Syst; 2004; 21(5):387-422. PubMed ID: 15719481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biopolymers and their derivatives: Key components of advanced biomedical technologies.
    Duceac IA; Coseri S
    Biotechnol Adv; 2022 Dec; 61():108056. PubMed ID: 36349602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chitosan hydrogels for sustained drug delivery.
    Peers S; Montembault A; Ladavière C
    J Control Release; 2020 Oct; 326():150-163. PubMed ID: 32562854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural and synthetic biomaterials for controlled drug delivery.
    Kim JK; Kim HJ; Chung JY; Lee JH; Young SB; Kim YH
    Arch Pharm Res; 2014 Jan; 37(1):60-8. PubMed ID: 24197492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.